Title : AZD0530 sensitizes drug-resistant ALK-positive lung cancer cells by inhibiting SRC signaling.

Pub. Date : 2017 Apr

PMID : 28396832






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AZD0530 sensitizes drug-resistant ALK-positive lung cancer cells by inhibiting SRC signaling. saracatinib SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens
2 Furthermore, SRC inhibition by AZD0530 was effective in ALK-resistant cancer cells. saracatinib SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens